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Abstract Understanding the cause of failure and type of
revision total knee arthroplasty (TKA) procedures per-
formed in the United States is essential in guiding research,
implant design, and clinical decision making in TKA. We
assessed the causes of failure and speciﬁc types of revision
TKA procedures performed in the United States using
newly implemented ICD-9-CM diagnosis and procedure
codes related to revision TKA data from the Nationwide
Inpatient Sample (NIS) database. Clinical, demographic,
and economic data were reviewed and analyzed from
60,355 revision TKA procedures performed in the United
States between October 1, 2005 and December 31, 2006.
The most common causes of revision TKA were infection
(25.2%) and implant loosening (16.1%), and the most
common type of revision TKA procedure reported was all
component revision (35.2%). Revision TKA procedures
were most commonly performed in large, urban, non-
teaching hospitals in Medicare patients ages 65 to 74. The
average length of hospital stay (LOS) for all revision TKA
procedures was 5.1 days, and the average total charges
were $49,360. However, average LOS, average charges,
and procedure frequencies varied considerably by census
region, hospital type, and procedure performed.
Level of Evidence: Level II, economic and decision
analysis. See Guidelines for Authors for a complete
description of levels of evidence.
Introduction
Total knee arthroplasty (TKA) is a clinically efﬁcacious and
cost-effective intervention, with high rates of success in
terms of alleviating pain and improving function in patients
with advanced arthritis of the knee [2, 11, 12, 21, 22, 25].
However, there has been a steady rise in the volume of
revision TKA procedures in the United States in recent
years. The increase in revision TKA procedures is related to
a number of factors, including an increase in primary TKA
procedure volumes, factors related to modiﬁcations in sur-
gical technique, patient selection, implant longevity, and an
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DOI 10.1007/s11999-009-0945-0expansion of the indications to include younger, more
active patients [16, 23]. Furthermore, recent estimates
suggest the number of revision TKA procedures is expected
to increase substantially over the next several decades [14].
Most of the information published regarding the causes
of failure and indications for revision TKA in the United
States comes from single-surgeon or single-center case
series, or multicenter cohort studies from large, academic
institutions [5, 6, 10, 19, 26, 28]. Limited information
currently exists regarding TKA failure among the larger
population of patients who undergo TKA at smaller,
community-based hospitals. Furthermore, due to the limi-
tations and lack of speciﬁcity associated with adminis-
trative codes related to revision TKA that existed until very
recently, previous investigators who attempted to charac-
terize the epidemiology of revision TKA using large
administrative databases were unable to provide insight
into the speciﬁc causes of failure or types of revision TKA
procedures performed [9, 15].
In 2005, a group of researchers from the American
Academy of Orthopaedic Surgeons and the American
Association of Hip and Knee Surgeons worked with ofﬁ-
cials from the Center for Medicare and Medicaid Services
(CMS) and the National Center for Health Statistics
(NCHS) to request a series of changes to the ICD-9-CM
diagnosis and procedure codes related to failed total joint
arthroplasties (TJA) and revision TJA procedures [4]. The
primary objective of the requested coding changes was to
provide more accurate and clinically descriptive
administrative codes regarding the cause of TJA failures
that could be used for tracking clinical outcomes, and
thereby facilitate feedback to surgeons, hospitals, and
medical device companies. Recognizing the potential
public health beneﬁts of having better information
regarding the cause of failure and type of revision TJA
procedure performed, CMS and the NCHS implemented
the requested changes in October 2005 (Table 1)[ 4]. As a
result of these administrative coding changes, it is now
possible for the ﬁrst time to use large administrative claims
databases to gather more detailed information on the cause
of failure and type of revision TKA procedure performed in
a nationally representative population.
The objectives of this study were to: (1) identify the
indications for revision TKA; (2) determine revision TKA
procedure frequencies; (3) evaluate adoption and usage of
the newly adopted ICD-9-CM diagnosis and procedure
codes related to revision TKA; (4) assess age, gender, race,
payor type and US Census Region of revision TKA
patients; and (5) ascertain length of stay and total charge by
type of revision TKA procedure.
Materials and Methods
We used the Nationwide Inpatient Sample (NIS) to identify
revision TKA procedures performed in the United States
between October 1, 2005 and December 31, 2006 using the
9th Revision of the International Classiﬁcation of Diseases
(ICD-9-CM) procedure codes 00.80 (all component revi-
sion), 00.81 (tibial component revision), 00.82 (femoral
component revision), 00.83 (patellar component revision),
00.84 (isolated tibial insert exchange), 80.06 (arthrotomy/
removal of prosthesis), and 81.55 (revision TKA, not
otherwise speciﬁed). The NIS is a stratiﬁed, statistically
valid survey of hospitals conducted by the Federal
Healthcare Cost and Utilization Project. Hospitals within
the sampling frame are stratiﬁed according to census
regions, ownership (eg, public, private), location (rural,
urban), teaching status, and bed size. Hospitals are ran-
domly selected to achieve an approximate 20% sample of
the universe of hospitals in each stratum. All discharge
records from each of the selected hospitals are collected
and form part of the NIS ﬁle for a given year. In 2006, the
NIS had a sample size of approximately 8 million records
from 1045 hospitals in 38 states, which represents
approximately 20% of all discharges from hospitals in the
United States, regardless of payment source. Because of
the large size of the database, the NIS is particularly well-
suited for epidemiological studies related to speciﬁc pro-
cedures or diseases in the national population. The total
sample size included in the analysis was 60,355 revision
TKA procedures with a mean patient age of 65.8 years.
Table 1. ICD-9-CM diagnosis and procedure codes related to revi-
sion TKA, introduced on October 1, 2005
Code Description
Diagnosis codes
996.41 Mechanical loosening of prosthetic joint
996.42 Dislocation of prosthetic joint
996.43 Prosthetic joint implant failure/breakage
996.44 Periprosthetic fracture around prosthetic joint
996.45 Periprosthetic osteolysis
996.46 Articular bearing surface wear of a prosthetic joint
996.47 Other mechanical complication of prosthetic joint implant
996.49 Other mechanical complication of other internal orthopedic
device, implant, or graft
Procedure codes
00.80 Revision of tibial, patellar, and femoral components
00.81 Revision of tibial component
00.82 Revision of femoral component
00.83 Revision of patellar component
00.84 Isolated revision of tibial insert
80.06 Arthrotomy/removal of prosthesis
81.55 Revision of knee, NOS
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123Men comprised 42.6% of the sample, and 83.3% of the
patients were white.
The prevalence of revision TKA procedures was cal-
culated using the NIS for population subgroups in the
United States stratiﬁed by age, gender, race, diagnosis,
census region, primary payor class, and hospital charac-
teristics (size, location [9], and teaching status). Cause of
failure, average length of hospital stay, and total charges
were also computed for each type of revision TKA
procedure.
Results
The most common causes of revision TKA (Table 2) were
infection (25.2%), mechanical loosening (16.1%), and
implant failure/breakage (9.7%). Infection was the most
common indication for arthrotomy/removal of prosthesis
(79.1%). Mechanical loosening was the most common
reason for all component revision, tibial component revi-
sion, femoral component revision, and patellar component
revision. Infection was the most common indication for
isolated tibial insert revision. Overall, 76.5% of all TKA
revisions were coded either using one of the newly
implemented ICD-9 diagnosis codes (53.3%) or with the
code for infection of an internal joint prosthesis (25.2%). In
addition, 8.7% of all revisions were coded as ‘‘other
mechanical complication of a prosthetic joint implant’’
(996.47), and 6.7% were coded as ‘‘other mechanical
complication of other internal orthopaedic device, implant,
or graft’’ (996.49).
Overall, 91% of all revision TKA procedures during the
time period under study were coded using at least one of
the newly implemented ICD-9 procedure codes (00.80 to
00.84) or the arthrotomy/removal of prosthesis procedure
code (80.06) (Table 3). The most common type of revision
TKA procedure reported during the time period under
study was all component revision (35.2%), followed by
Table 2. Diagnosis codes associated with revision TKA procedures
Diagnosis codes Total, all
revisions
00.80 All
component
revision
00.81 Tibial
component
revision
00.82
Femoral
component
revision
00.83
Patellar
component
revision
00.84
Isolated
tibial insert
revision
80.06
Arthrotomy
removal of
prosthesis
81.55 Knee
revision,
NOS
Number of
Revisions
60,436 21,285 5774 2436 3122 5483 9202 5678
996.41
Mechanical
loosening
9711 (16.1%) 4072 (19.1%) 1421 (24.6%) 562 (23.1%) 430 (13.8%) 270 (4.9%) 427 (4.6%) 730 (12.8%)
996.42
Dislocation
4268 (7.1%) 1459 (6.9%) 472 (8.2%) 262 (10.8%) 380 (12.2%) 526 (9.6%) 176 (1.9%) 397 (7.0%)
996.43 Implant
failure/breakage
5852 (9.7%) 2542 (11.9%) 648 (11.2%) 246 (10.1%) 396 (12.7%) 437 (8.0%) 158 (1.7%) 539 (9.5%)
996.44
Periprosthetic
fracture
900 (1.5%) 309 (1.5%) 121 (2.1%) 78 (3.2%) 33 (1.1%) 14 (0.3%) 64 (0.7%) 77 (1.4%)
996.45
Periprosthetic
osteolysis
1910 (3.2%) 919 (4.3%) 140 (2.4%) 111 (4.5%) 30 (1.0%) 174 (3.2%) 80 (0.9%) 64 (1.1%)
996.46 Bearing
surface wear
2967 (4.9%) 917 (4.3%) 419 (7.3%) 43 (1.8%) 195 (6.2%) 630 (11.5%) 15 (0.2%) 170 (3.0%)
996.47 Other
mechanical
complication of
prosthetic joint
implant
5247 (8.7%) 2148 (10.1%) 634 (11.0%) 316 (13.0%) 389 (12.5%) 405 (7.4%) 122 (1.3%) 529 (9.3%)
996.49 Other
mechanical
complication of
other internal
orthopedic
device implant
or graft
4040 (6.7%) 1722 (8.1%) 492 (8.5%) 171 (7.0%) 277 (8.9%) 217 (4.0%) 202 (2.2%) 410 (7.2%)
996.66 Infection 15,233 (25.2%) 2902 (13.6%) 657 (11.4%) 236 (9.7%) 173 (5.5%) 1710 (31.2%) 7281 (79.1%) 1107 (19.5%)
Note: Multiple diagnosis codes allowed.
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123arthrotomy/removal of prosthesis (15.2%) and tibial com-
ponent revision (9.5%). All component revisions, patellar
component revisions, and isolated tibial component revi-
sions were most commonly reported in the 65- to 74-year-
old age group (30.2%, 33.9%, and 29%, respectively),
while femoral component revisions were more commonly
reported in patients age 55 to 64 (28.8%). Revision TKA
procedures were most commonly reported in urban non-
teaching hospitals (48.8%), compared with 41.2% in urban
teaching hospitals, and only 9.9% in rural hospitals.
Large hospitals accounted for the highest percentage of
revision TKA procedures (61.3%), while only 13.7% of
revision TKAs were reported in small hospitals. Medicare
was the primary payor for 59.5% of revision TKA proce-
dures, whereas private insurance patients and Medicaid
patients accounted for 31% and only 3.5% of cases,
respectively. Geographically, the highest percentage of
revision TKA procedures were reported in the South
(37.5%), and the lowest percentage of revision procedures
were reported in the Northeast (16.3%) (Table 4). Average
length of stay and total charges also differed by U.S.
Census region. The shortest average length of stay
(4.8 days) was reported in the Midwest and the West,
compared with the longest average length of stay
(5.8 days) in the Northeast. Average total charges for
revision TKA procedures were highest in the West
($61,465), and were 1.4 times the average total charges for
revision TKA procedures in the Midwest ($43,527).
The evaluation of resource utilization (Table 5) revealed
the average hospital length of stay for all types of revision
TKA procedures was 5.1 days; arthrotomy/removal of
prosthesis procedures were associated with the longest
length of stay (8.1 days) and patellar component revision
were associated with the shortest length of stay (3.4 days).
The average billed charges for all types of revision TKA
procedures were $49,360. All component revisions had the
Table 3. Revision TKA procedure frequencies by primary payor class
Procedure Primary payor class
Medicare Medicaid Private Other All
00.80 All component revision 12,665 (21.0%) 573 (0.9%) 6776 (11.2%) 1252 (2.1%) 21,267 (35.2%)
00.81 Tibial component revision 3275 (5.4%) 201 (0.3%) 1966 (3.3%) 320 (0.5%) 5762 (9.5%)
00.82 Femoral component revision 1317 (2.2%) 107 (0.2%) 810 (1.3%) 197 (0.3%) 2431 (4.0%)
00.83 Patellar component revision 2020 (3.3%) 124 (0.2%) 823 (1.4%) 155 (0.3%) 3122 (5.2%)
00.84 Isolated tibial insert exchange 3216 (5.3%) 243 (0.4%) 1669 (2.8%) 349 (0.6%) 5478 (9.1%)
80.06 Arthrotomy/removal of prosthesis 5629 (9.3%) 411 (0.7%) 2622 (4.3%) 530 (0.9%) 9191 (15.2%)
81.55 Knee revision NOS 3198 (5.3%) 209 (0.3%) 1884 (3.1%) 377 (0.6%) 5668 (9.4%)
Other combinations 4604 (7.6%) 251 (0.4%) 2150 (3.6%) 452 (0.7%) 7451 (12.3%)
Total 35,924 (59.5%) 2119 (3.5%) 18,700 (30.9%) 3632 (6.0%) 60,375 (100.0%)
Table 4. Revision TKA procedure demographics by U.S. census region
Procedure U.S. census region
Northeast Midwest South West Total
00.80 All component revision 3298 (5.5%) 6079 (10.1%) 7785 (12.9%) 4123 (6.8%) 21,285 (35.2%)
00.81 Tibial component revision 804 (1.3%) 1648 (2.7%) 2174 (3.6%) 1149 (1.9%) 5774 (9.6%)
00.82 Femoral component revision 311 (0.5%) 660 (1.1%) 1008 (1.7%) 457 (0.8%) 2436 (4.0%)
00.83 Patellar component revision 541 (0.9%) 788 (1.3%) 1261 (2.1%) 532 (0.9%) 3122 (5.2%)
00.84 Isolated tibial insert exchange 911 (1.5%) 1394 (2.3%) 1969 (3.3%) 1209 (2.0%) 5483 (9.1%)
80.06 Arthrotomy/removal of prosthesis 1560 (2.6%) 2370 (3.9%) 3576 (5.9%) 1695 (2.8%) 9202 (15.2%)
81.55 Knee revision, NOS 1166 (1.9%) 1474 (2.4%) 2309 (3.8%) 729 (1.2%) 5678 (9.4%)
Other combinations 567 (0.9%) 665 (1.1%) 1000 (1.7%) 615 (1.0%) 2847 (4.7%)
Total 9836 (16.3%) 16,509 (27.3%) 22,681 (37.5%) 11,410 (18.9%) 60,436 (100.0%)
Northeast = Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, Pennsylvania. Mid-
west = Indiana, Illinois, Michigan, Ohio, Wisconsin, Iowa, Nebraska, Kansas, North Dakota, Minnesota, South Dakota, Missouri.
South = Delaware, District of Columbia, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia, Alabama,
Kentucky, Mississippi, Tennessee, Arkansas, Louisiana, Oklahoma, Texas. West = Arizona, Colorado, Idaho, New Mexico, Montana, Utah,
Nevada, Wyoming, Alaska, California, Hawaii, Oregon, Washington.
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123highest average billed charges ($56,087), while patellar
component revision procedures had the lowest average
billed charges ($26,047).
Discussion
Despite the excellent functional outcomes and long-term
implant survivorship that have been reported with primary
TKA [2, 5, 28], TKA failure and revision TKA remain
substantial clinical challenges for orthopaedic surgeons and
their patients. Furthermore, despite continual changes in
surgical technique and implant design, the revision TKA
burden (eg, the percentage of revision TKA cases as a
function of all TKA cases) in the United States has not
decreased over time [3, 16, 17]. Understanding the causes
of TKA failure and types of TKA procedures performed
are essential to improving implant performance and long-
term patient outcomes. We therefore: (1) identiﬁed the
indications for revision TKA; (2) determined revision TKA
procedure frequencies; (3) evaluated adoption and usage of
the newly adopted ICD-9-CM diagnosis and procedure
codes related to revision TKA; (4) assessed age, gender,
race, payor type and US Census Region of revision TKA
patients; and (5) ascertained length of stay and total charge
by type of revision TKA procedure.
Our ﬁndings are limited by a relatively short time period
of data collection, and uncertain compliance and accuracy
of coding related to both the diagnosis/cause of failure and
the type of revision procedure performed. However, the
administrative codes used in this study are currently being
used by governmental and nongovernmental public
reporting agencies to compare failure rates and revision
rates among surgeons and hospitals. Therefore, it is
important for the surgeon community to be aware of
strengths and limitations of this data, and the importance of
detailed clinical documentation in order to improve the
accuracy and clinical relevance of administrative codes
related to TKA failure and revision TKA. Further study
will be necessary to determine if our ﬁndings persist in
larger data sets encompassing longer time periods.
Although our results represent only the early experience
with the new ICD-9 diagnosis and procedure codes over a
relatively short time period (15 months), the large number
of procedures (over 60,000) included in our analysis pro-
vides unique and previously unavailable insight into the
current causes of revision TKA procedures in a wide
variety of care delivery settings throughout the entire
United States. Since the existing literature contains limited
information regarding the causes of TKA failure in large
populations, it is difﬁcult to compare our ﬁndings to those
of previous investigators. Sharkey et al. [26] reported that
polyethylene wear, aseptic loosening, and instability were
the most common causes of revision TKA in a series of 203
consecutive revision TKAs performed over a 3-year period
at a single institution. Other investigators [8, 18–20, 27]
have implicated aseptic loosening, polyethylene wear,
osteolysis, pain, stiffness, and instability as common causes
of TKA failure. However, similar to the ﬁndings of Fehring
et al. [6] and Vessely et al. [28], both of whom reported
infection as a frequent mode of TKA failure, our data
indicate that prosthetic joint infection is currently the most
common indication for revision TKA in the United States.
This is particularly concerning, especially given the sub-
stantial resources required to treat prosthetic joint
infections, and the relatively poor patient outcomes that
have been reported with both single- and two-stage revi-
sion TKA for infection compared with the results of
revision TKA for aseptic causes of failure [1, 7, 13, 24, 29].
As the number of primary TKA procedures performed in
the next two decades is expected to rise exponentially [14],
increased resources should be devoted to research investi-
gation and product development focused on prevention,
early diagnosis, and treatment of prosthetic joint infection.
Table 5. Revision TKA procedure average length of stay (LOS) and average total hospital charges
Procedure Total Average age
(years)
Gender
(% female)
Race
(% white)
Average LOS
(days)
Average total
charge
00.80 All component revision 21,285 66.0 57.2 83.3 4.5 $56,087
00.81 Tibial component revision 5774 65.1 63.6 84.0 4.2 $36,193
00.82 Femoral component revision 2436 63.4 57.2 81.6 4.7 $51,261
00.83 Patellar component revision 3122 67.0 58.1 85.2 3.4 $26,047
00.84 Isolated tibial insert exchange 5483 65.9 57.6 85.3 4.8 $32,511
80.06 Arthrotomy/removal of prosthesis 9202 65.6 51.3 83.0 8.1 $54,229
81.55 Knee revision, NOS 5678 65.7 58.7 78.8 4.7 $48,208
Other combinations 7456 65.7 55.6 82.6 6.9 $58,371
Total 60,436 65.8 57.4 83.3 5.1 $49,360
Note: Demographic percentages, LOS, and charges computed from known values only.
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123The newly implemented ICD-9-CM diagnosis and pro-
cedure codes related to revision TKA provide valuable
insight into the cause of failure and type of revision TKA
procedureperformed. Our analysis suggeststhat adoptionof
the new revision TKA-related ICD-9-CM procedure codes
(by hospital administrative coding personnel) and diagnosis
codes(bysurgeons)isrelativelyhigh,butcouldbeimproved
with additional education and training regarding the
appropriate use of these new codes. Speciﬁcally, it appears
that some of the codes may be ambiguous as currently
deﬁned, (eg,ICD-9diagnosiscode 996.43, ‘‘implantfailure/
breakage’’), which may be creating some confusion among
both clinicians and coding personnel. Also, inadequate
clinical documentation may have accounted for the rela-
tively large percentage of cases (15.4%) that were coded as
‘‘other mechanical complications.’’ Furthermore, it is pos-
sible that certain isolated tibial liner exchange procedures
are being incorrectly coded by hospital coding personnel as
tibial component revisions, which could be artiﬁcially
inﬂating the prevalence of tibial component revision pro-
cedures in administrative databases. The value of these new
administrative diagnosis and procedure codes in terms of
understanding the cause of TKA failure and monitoring
trends in failure rates and speciﬁc types of revision proce-
dures will be dependent on a clear understanding of the
description and the intended meaning of each code, detailed
and unambiguous clinical documentation, and appropriate
use of the new codes when submitting administrative claims
related to revision TKA procedures. The validity of the
administrative claims data is expected to improve as sur-
geons and administrative coding personnel become more
familiar with their deﬁnitions and appropriate usage.
Although useful information related to TKA failures can
be derived from clinical case series and cohort studies, our
study illustrates the value of large administrative databases
in evaluating the epidemiology of revision TKA in a large
population. However, although the newly implemented
ICD-9-CM diagnosis and procedure codes reviewed in this
study would provide valuable data elements for a U.S. Joint
Replacement Registry, they should not be considered an
acceptable substitute for a true TJR registry, as they lack
essential information regarding the speciﬁc implants used
in a procedure, and other important clinical and demo-
graphic information. As experience is gained with the new
ICD-9-CM diagnosis and procedure codes related to revi-
sion TKA, valuable insight will be gained into TKA failure
mechanisms, which may help guide future research,
implant design, and clinical decision making related to
total knee arthroplasty.
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